Resurgent Biosciences, a subsidiary of Goodness Growth Holdings, Inc. (CSE: GDNS) (OTCQX: GDNSF), is launching a survey study that will look into the varying effects of entheogen and psychedelic experiences for therapeutic, religious and spiritual purposes.
The goal of the company is to understand the naturalistic use of entheogens and other substances typically used for healing in specific cultural and spiritual contexts.
Goodness Growth recently changed its name from Vireo Health in a move to encompass the psychedelics and natural medicine space, expanding beyond its cannabis MSO operations.
A Survey Into Traditional Psychedelics Use
The study’s approach seeks to complement …